BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Infographics: Dynamic digital data analysis
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Israel
Rise of obesity
Radiopharmaceuticals
Biosimilars
Aging
IVDs on the rise
Coronavirus
Artificial intelligence
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Wednesday, December 18, 2024
Home
»
Newsletters
» BioWorld
BioWorld
Oct. 14, 2003
View Archived Issues
FDA Accepts ImClone's Erbitux Filing, Grants It Priority Review
Read More
Elixir Pharmaceuticals Gets $19M In Second B' Round
Read More
Georgia, Among Others, Seeking To Grow Through Life Sciences
Read More
Xcyte Seeking $75M In Second Attempt At Initial Public Offering
Read More
Other News To Note
Read More
Corgentech, BMS Enter Graft Deal Valued At Up To $250M
With two Phase III trials under way testing its treatment to prevent vein-graft failure after surgery, Corgentech Inc. is joining with Bristol-Myers Squibb Co. in a deal that's expected to get revenue flowing better. (BioWorld Today)
Read More